Skip to main content

Supplementary Table 1 Characteristics of patients in the study

From: Circulating cytotoxic CD8+ CD28- T cells in ankylosing spondylitis

  Patient value Normal range
Duration of AS since 9.9 ± 9.3  
diagnosis (years)   
Time since onset of 16.6 ± 12.2  
symptoms (years)   
ESR (mm/hour) 31.4 ± 20.3 <15
Leucocytes (G/I) 9.08 ± 1.92 3.8–10.5
Erythrocytes (T/I) 4.88 ± 0.59 3.9–5.7
Platelets (G/I) 344 ± 99 140–345
HAQ-S score (0–3) 0.89 ± 0.51  
BASFI (0–10) 4.67 ± 2.05  
BASMI (0–10) 5.04 ± 2.20  
  1. AS, ankylosing spondylitis; BASFI, Bath Ankylosing Spondylitis Functional Index; BASMI, Bath Ankylosing Spondylitis Metrology Index; ESR, erythrocyte sedimentation rate; HAQ-S = Health Assessment Questionnaire; G/l, giga/liter; T/l, tara/liter.